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Dear Editor,
Gestational pemphigoid (GP) is a rare autoim-
mune bullous dermatosis in pregnancy. GP usually 
occurs during the second or third month of preg-
nancy. It clinically manifests as the development of 
either early-onset urticarial lesions or late-onset sub-
epidermal blisters that may linger for weeks or even 
months. Herein we report the case of a 45-year-old 
woman with the distinctive clinical onset of GP.
A forty-five-year-old woman, gravida I, para 0, at 
27 weeks gestation, was referred for evaluation to 
our Department with an extensive pruritic eruption 
that had developed over the previous 7 days. The le-
sions had first appeared on the proximal thighs and 
extended progressively to the abdomen.
On physical examination, numerous round ur-
ticarial plaques of approximately 1 cm in diameter 
were noted on her abdomen, involving the perium-
bilical area. Her thighs and back were also affected 
(Figures 1 and 2). The palms and soles were spared. 
No mucosal involvement was seen.
The patient medical history was unremarkable, 
and she denied use of any other medications or 
herbal remedies at the time the symptoms started or 
since. No other symptoms but pruritus were referred.
Laboratory studies, including complete blood cell 
count, coagulation tests, and renal and hepatic func-
tion were all normal. A punch biopsy was taken from 
an urticarial plaque and stained with hematoxylin 
and eosin. Histological examination found spongiosis 
in combination with an intraepidermal eosinophilic 
infiltrate, without the development of blisters (Figure 
3). Direct immunofluorescence of perilesional skin 
showed linear deposition of complement (C3) along 
the basement membrane zone (Figure 4).
Serum antibody titers for BP180NC16a were detect-
ed by enzyme-linked immunosorbent assay (ELISA). We 
established a diagnosis of gestational pemphigoid.
Our patient was treated with systemic glucocor-
ticoids, no blisters developed, and lesions cleared 8 
weeks after delivery. The newborn girl did not devel-
oped neonatal gestational pemphigoid. 
Gestational pemphigoid, originally misnamed 
herpes gestationis, is a rare autoimmune bullous 
dermatosis in pregnancy. Single cases have been 
also described in patients with molar pregnancies 
and trophoblastic tumors (1). Its etiology is based in 
the development of autoantibodies against the feto-
placental unit, triggering an autoimmune response 
against both skin and amnion hemidesmosomal pro-
teins, mainly BP180, but also BP230 and type VII col-
lagen. An association with HLA-DR3 and HLA-DR4 has 
been described (2).
Figure 1. Numerous round urticarial plaques on the abdo-
men.
Figure 2. Numerous round urticarial plaques on the 
thighs.
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GP usually occurs during the second or third 
month of pregnancy, but it may appear at any time 
during pregnancy or puerperium. In the vast majority 
of cases, symptoms alleviate a few weeks before de-
livery, but they reemerge at the time of delivery. Re-
currences are frequent in following pregnancies, with 
an earlier onset and more severe symptoms, and may 
occur during subsequent menstruations or hormonal 
contraceptive use (1).
GP clinically consists of the development of either 
early-onset urticarial lesions or late-onset subepider-
mal blisters that mat linger for weeks or even months. 
They generally appear on the abdomen, specifically 
in the periumbilical area, with posterior widespread 
extension to proximal limbs. Facial and mucosal le-
sions are uncommon (1).
Histopathological studies are necessary to estab-
lish the diagnosis. These findings vary depending on 
the stage and severity of the disease and include sub-
epidermal blisters, papillary dermal edema, eosino-
philic spongiosis, and a polymorphous perivascular 
inflammatory cell infiltrate with a predominance of 
eosinophils. Direct immunofluorescence of perile-
sional skin shows a linear deposition of C3 along the 
basement membrane zone in all cases. IgG deposits 
can also be seen (3). These deposits are located within 
the lamina lucida and localized to the proximal part 
of anchoring filaments of the epidermal fragment of 
salt-split skin (4). Moreover, immunoblot and ELISA of 
the NC16a domain of BP180 RP are highly sensitive 
diagnostic methods in GP (5).
The aim of treatment is to alleviate the pruritus 
and prevent formation of new blisters. Topical cortico-
steroids and oral antihistamines may be used in mild 
cases. Systemic corticosteroids are the treatment of 
choice in moderate to severe cases. Other treatments 
that have been used are cyclophosphamide, dap-
sone, gold, methotrexate, and plasmapheresis (5).
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Figure 3. Cutaneous biopsy revealed eosinophilic spongio-
sis (hematoxylin and eosin, original magnification ×40).
Figure 4. Direct immunofluorescence examination of per-
ilesional skin showing linear staining with C3 at the base-
ment membrane.
ACTA DERMATOVENEROLOGICA CROATICA
Letter to the editor Acta Dermatovenerol Croat
    2018;26(1):71-72
